Alzamend Neuro

ALZNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.564 M

$1.37 -0.72%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$8.77M

Loss-making

Shares outstanding

4,791,525

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#455ImunonIMNN$6.77M
#456Acurx PharmaceuticalsACXP$6.62M
#457Alzamend NeuroALZN$6.56M
#458FibroBiologicsFBLG$6.50M
#459Apimeds Pharmaceuticals USAPUS$6.38M

Where these numbers come from

Share counts and financials for Alzamend Neuro are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.